Is ventilated hospital-acquired pneumonia a worse entity than ventilator-associated pneumonia?
نویسندگان
چکیده
منابع مشابه
Critical illness related pneumonia rather than Ventilator-Associated Pneumonia (VAP).
tubation. During spontaneous breathing without an artificial airway (normal breathing), an open airway is a prerequisite for breathing. This fact is violated in clinical practice. When we evaluate a patient for extubation (a transition to breathing without an artificial airway), we frequently evaluate the breathing pattern first and then decide if the patient can keep the airway open. We believ...
متن کاملClinical utility of telavancin for treatment of hospital-acquired pneumonia: focus on non-ventilator-associated pneumonia
BACKGROUND Hospital-acquired pneumonia (HAP) is the most common health care-associated infection contributing to death. Studies have indicated that there may be differences in the causative pathogens and outcomes of ventilator-associated pneumonia (VAP) and non-ventilator-associated pneumonia (NV-HAP). However, with limited NV-HAP-specific data available, treatment is generally based on data fr...
متن کاملMicrobiology of ventilator-associated pneumonia compared with that of hospital-acquired pneumonia.
OBJECTIVE Nosocomial pneumonia is the leading cause of mortality attributed to nosocomial infection. Appropriate empirical therapy has been associated with improved survival, but data are limited regarding the etiologic agents of hospital-acquired pneumonia in nonventilated patients (HAP). This evaluation assessed whether the currently recommended empirical therapy is appropriate for both venti...
متن کاملVentilator associated pneumonia or ventilator induced pneumonia
Ventilator associated pneumonia currently in vogue seems to have some pitfalls as far as the nomenclature is concerned and thus it imparts an erroneous impression to the reader. As the driving force is in fact the ventilator, the phraseology should preferably be changed to ventilator induced pneumonia to convey the in depth meaning of the term thus evading the terminology currently in practice....
متن کاملConsiderations unique to pediatrics for clinical trial design in hospital-acquired pneumonia and ventilator-associated pneumonia.
Background. A need exists for new antimicrobial agents to treat neonates, infants, and children for hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) caused by nosocomial antibiotic-resistant pathogens. Current and clear guidance on approval of new agents for all pediatric age groups is lacking. Methods. Studies on HAP and VAP in the neonatal and pediatric age groups w...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Respiratory Review
سال: 2020
ISSN: 0905-9180,1600-0617
DOI: 10.1183/16000617.0023-2020